The challenges of introducing routine G6PD testing into radical cure: A workshop report

• Main Authors: Benedikt Ley, Nick Luter, Fe Esperanza Espino, Angela Devine, Michael Kalnoky, Yoel Lubell, Kamala Thriemer, J. Kevin Baird, Eugenie Poirot, Nolwenn Conan, Chong Chee Kheong, Lek Dysoley, Wasif Ali Khan, April G. Dion-Berboso, Germana Bancone, Jimee Hwang, Ritu Kumar, Ric N. Price, Lorenz Von Seidlein, Gonzalo J. Domingo
• Other Authors: Menzies School of Health Research
• Format: Article
• Published: 2018
• Subjects: Immunology and Microbiology; Medicine
• Online Access: https://repository.li.mahidol.ac.th/handle/123456789/36072
• Institution: Mahidol University

© 2015 Ley et al. The only currently available drug that effectively removes malaria hypnozoites from the human host is primaquine. The use of 8-aminoquinolines is hampered by haemolytic side effects in glucose-6-phosphate dehydrogenase (G6PD) deficient individuals. Recently a number of qualitative...